In 2017 Bliss Pharma established own subsidiaries in Vietnam, Myanmar, Cambodia, Ecuador, Guatemala and India.
During 2019 - 2020 Bliss Pharma launched 31 products in Philippines focussing on critical care, cardio, ophthalmology and oncology segment.
At the end of 2020 Bliss pharma successfully launched 31 products collectively in Cambodia, Vietnam, Ecuador, Myanmar and Guatemala comprising multiple therapeutic segments like Antibacterial, Oncology, Critical Care, Antivirals etc.
Bliss pharma targets to launch more than 35 new products in Philippines by 2022 and 30 new products in South East Asia and Latin American countries.
Bliss Pharma is first and foremost a marketing and distribution company. We also provide registration consultancy services to our local and international partners
BLISS PHARMA’s mission is to Register, Import and market safe, effective and quality medicines and health care products that will improve the health and quality of life of men, women and children.
BLISS PHARMA pledges to prioritize the patient safety always.
To be the prime Pharmaceutical Company, delivering quality products and service to our customers and effectively contributing in health care of the nation.